DE3770830D1 - Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion. - Google Patents

Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.

Info

Publication number
DE3770830D1
DE3770830D1 DE8787850029T DE3770830T DE3770830D1 DE 3770830 D1 DE3770830 D1 DE 3770830D1 DE 8787850029 T DE8787850029 T DE 8787850029T DE 3770830 T DE3770830 T DE 3770830T DE 3770830 D1 DE3770830 D1 DE 3770830D1
Authority
DE
Germany
Prior art keywords
water emulsion
pregnanolol
preparation
stable oil
pregnanolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787850029T
Other languages
English (en)
Inventor
Roland Ingolf Jeppsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of DE3770830D1 publication Critical patent/DE3770830D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
DE8787850029T 1986-02-13 1987-01-29 Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion. Expired - Fee Related DE3770830D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (1)

Publication Number Publication Date
DE3770830D1 true DE3770830D1 (de) 1991-07-25

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787850029T Expired - Fee Related DE3770830D1 (de) 1986-02-13 1987-01-29 Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.

Country Status (14)

Country Link
US (1) US5028600A (de)
EP (1) EP0233849B1 (de)
JP (1) JPH0788305B2 (de)
AT (1) ATE64526T1 (de)
CA (1) CA1301651C (de)
DE (1) DE3770830D1 (de)
DK (1) DK175504B1 (de)
ES (1) ES2037742T3 (de)
FI (1) FI88676C (de)
GR (1) GR3002299T3 (de)
HK (1) HK83293A (de)
NO (1) NO175040B (de)
SE (1) SE8600632D0 (de)
SG (1) SG102892G (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US6117429A (en) * 1997-08-11 2000-09-12 Weider Nutrition International, Inc Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
US20020155161A1 (en) * 2000-12-29 2002-10-24 Deckelbaum Richard J. Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
PL224989B1 (pl) * 2002-07-02 2017-02-28 Nycomed Gmbh Sposób wytwarzania sterylnej wodnej zawiesiny zawierającej cyklezonid
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
BRPI0515181A (pt) * 2004-09-13 2008-07-22 Bharat Serums & Vaccines Ltd composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa
CN104739765A (zh) * 2011-01-14 2015-07-01 卡思伯特·O·辛普金斯 用于处理与缺乏血液供给、休克和神经损伤相关的疾病的方法和组合物
WO2013043985A1 (en) * 2011-09-23 2013-03-28 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
IL298436B1 (en) 2012-01-23 2024-03-01 Sage Therapeutics Inc Pharmaceutical preparations that include allopregnanolone
US20140050789A1 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
US20150313915A1 (en) 2012-11-30 2015-11-05 The Regents Of The University Of California Anticonvulsant activity of steroids
MA43815A (fr) 2016-03-08 2021-04-07 Sage Therapeutics Inc Stéroïdes neuroactifs, compositions, et leurs utilisations
WO2020123551A1 (en) * 2018-12-10 2020-06-18 Halo Science LLC Stable formulations of anesthetics and associated dosage forms
EP4017498A4 (de) * 2019-08-19 2022-11-09 Arizona Board of Regents on behalf of the University of Arizona Topische neurosteroidformulierungen
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
ATE64526T1 (de) 1991-07-15
DK62187D0 (da) 1987-02-06
NO175040C (de) 1994-08-24
EP0233849B1 (de) 1991-06-19
SG102892G (en) 1992-12-04
ES2037742T3 (es) 1993-07-01
NO175040B (no) 1994-05-16
JPS62192322A (ja) 1987-08-22
DK62187A (da) 1987-08-14
CA1301651C (en) 1992-05-26
SE8600632D0 (sv) 1986-02-13
FI88676B (fi) 1993-03-15
US5028600A (en) 1991-07-02
FI870589A0 (fi) 1987-02-12
FI870589A (fi) 1987-08-14
NO870560D0 (no) 1987-02-12
HK83293A (en) 1993-08-20
EP0233849A1 (de) 1987-08-26
FI88676C (fi) 1993-06-28
GR3002299T3 (en) 1992-12-30
DK175504B1 (da) 2004-11-15
NO870560L (no) 1987-08-14
JPH0788305B2 (ja) 1995-09-27

Similar Documents

Publication Publication Date Title
DE3770830D1 (de) Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
EP0339237A3 (de) Phenol-substituierte Gem-Diphosphonat-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
KR910021361A (ko) 항궤양 물질
DK578887A (da) Antihypertensiva
IT8722869A0 (it) Soluzioni iniettabili pronte all'uso contenenti un glicoside antraciclinico antitumorale.
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
KR880012226A (ko) 외 용 제
ES2016376B3 (es) Acido n,n-bis-(4-fluorofenil) carbamoilacetohidroxamico y composicion farmaceutica que lo contiene.
FR2382237A1 (fr) Nouvelles preparations de serum sanguin a base de mercaptans, leur procede de preparation et medicament les contenant
KR880000094A (ko) 위염치료제
DE68906449D1 (de) Herstellung von 2,6-dioxopiperidinderivate.
SE8505801L (sv) I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa
ES8303324A1 (es) "procedimiento para preparar una sustancia activa adecuada para la estabilizacion de prostaglandinas y sus derivados".
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
KR910011258A (ko) 녹내장의 치료방법
KR920000327A (ko) 비스(3,5-디-알킬-4- 히드록시페닐티오) 메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물
KR930012025A (ko) 한방성 b형 간염치료제
SE8704049D0 (sv) Novel pharmacological compounds
ES2076517T3 (es) Ergolinas disustituidas en posiciones 2,13, su preparacion y utilizacion en medicamentos.
KR830006182A (ko) 신규한 옥시아세트산 유도체, 그의 제법 및 그것을 유효성분으로 하는 혈중지질 저하제(血中脂質低下劑)
ATE89278T1 (de) Herstellung von 2,6-dioxopiperidinderivate.
TH2562B (th) ((บิส(แอริล)เมธิลีน)-1-พิเพอริดินิล) แอลคิล-พิริมิดิโนน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee